glp-1 and prostate cancer GLP1 Receptor Agonists—Effects beyond Obesity Diabetes May Patients Receiving GLP-1 Agonists

In the landmark 68-week STEP-1 trial, adults with overweight or obesity who reached the 2.4 mg maintenance dose lost roughly 15% of their body weight on average a magnitude that had previously belonged to bariatric surgery, not an injection

MyNetDiary brings those workflows together in one nutrition platform, pairing injection reminders and symptom logging with detailed nutrient tracking, Professional Connect for healthcare professionals, an in-app Community supported by registered dietitians, and a growing library of RD-written GLP-1 content

Se siente ms activa y sus niveles de energa aumentan, lo que le permite incorporar ms ejercicio a su rutina diaria

As with all medications, there are adverse effects

While this effect contributes to the appetite-suppressing benefits of the medication, it can initially cause feelings of fullness, queasiness, and general digestive discomfort